Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Key Blood Molecular Markers for Immunotherapy

NCT00507702 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00507702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00507702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Key Blood Molecular Markers for Immunotherapy
Lead sponsor
Stanford University
Phase
Observational
Overall status
Terminated
Start date
July 6, 2006
Completion date
February 25, 2015
Enrollment
191 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, neoplasms, squamous cell carcinoma